N
Market Data
$33.68−$4.88 (−12.66%)
NAMS · Last trade
Prev Close
$38.56
Range (29d)
$33.68 – $41.45
Recent Filings
- SC 13D/A169.4 KBNewAmsterdam Pharma Co N.V.Dec 17, 5:35 PM ET·0001193125-24-280575
- SC 13D/A96.7 KBNewAmsterdam Pharma Co N.V.Dec 17, 4:00 PM ET·0001193125-24-280472
- SC 13D/A335.5 KBNewAmsterdam Pharma Co N.V.Dec 17, 10:28 AM ET·0001193125-24-280208
- 8-K813.5 KBNewAmsterdam Pharma Co N.V.Dec 13, 8:28 AM ET·0001193125-24-277937
- 8-K186.1 KBNewAmsterdam Pharma Co N.V.Dec 10, 4:01 PM ET·0001193125-24-274327
- 8-K8.1 MBNewAmsterdam Pharma Co N.V.Dec 10, 7:24 AM ET·0001193125-24-273959
- 8-K6.2 MBNewAmsterdam Pharma Co N.V.Nov 20, 7:07 AM ET·0001193125-24-262125
- 8-K268.7 KBNewAmsterdam Pharma Co N.V.Nov 18, 4:11 PM ET·0001193125-24-260923
- SC 13G/A92.0 KBNewAmsterdam Pharma Co N.V.Nov 14, 5:46 PM ET·0001104659-24-119286
- 10-Q6.4 MBNewAmsterdam Pharma Co N.V.Nov 6, 8:00 AM ET·0000950170-24-121828
Insiders
10- Audet Juliette BerangereChief Business Officer
- Bain Capital Life Sciences Fund II, L.P.10% Owner
- Bain Capital Life Sciences Investors, LLC10% Owner
- BCIP Life Sciences Associates, LP10% Owner
- BCLS II Investco, LP10% Owner
- Davidson Michael H.Director, Chief Executive Officer
- Forbion Capital Fund IV Cooperatief U.A.10% Owner
- Forbion Growth Opportunities Fund I Cooperatief U.A.10% Owner
- JONES WILLIAM A JRChief Commercial Officer
- Joustra WouterDirector
Tickers
Addresses
business
GOOIMEER 2-35
NARRDEN, P7, 1411 DC
mailing
GOOIMEER 2-35
NARRDEN, P7, 1411 DC
Former Names
- NewAmsterdam Pharma Co B.V.2022-11-22